Relationship between Cannabinoid CB₁ and Dopamine D₂ Receptors in Intestinal Motility in Mice

By Carai M.A.M.   Agabio R.   Lobina C.   Pani M.   Reali R.   Vacca G.   Colombo G.   Gessa G.L.  

Pharmacy and Pharmacology Communications, Vol. 6, Iss. 6, 2000-06 ,pp. : 287-291

Pharmaceutical Press

Access to resources Recommend Favorite

Inhibition of intestinal motility by anandamide, an endogenous cannabinoid

By Calignano A.   La Rana G.   Makriyannis A.   Lin S.Y.   Beltrano M.   Piomelli D.  

European Journal of Pharmacology, Vol. 340, Iss. 2, 1997-12 ,pp. : 7-8

Elsevier

Access to resources Recommend Favorite

Modulation of gastric emptying and gastrointestinal transit in rats through intestinal cannabinoid CB 1 receptors

By Landi M.   Croci T.   Rinaldi-Carmona M.   Maffrand J.-P.   Le Fur G.   Manara L.  

European Journal of Pharmacology, Vol. 450, Iss. 1, 2002-08 ,pp. : 77-83

Elsevier

Access to resources Recommend Favorite

The Role of Cannabinoid Receptors in Renal Diseases

By  

Current Medicinal Chemistry, Vol. 25, Iss. 7, 2018-03 ,pp. : 793-801

Bentham Science Publishers

Access to resources Recommend Favorite

Cannabinoid Receptors and Endocannabinoids: Role in Neuroinflammatory and Neurodegenerative Disorders

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 5, 2010-11 ,pp. : 564-573

Bentham Science Publishers

Access to resources Recommend Favorite